Whoops. Looks like we neglected to hit the send button earlier. Our apologies. Normally, we prefer to greet you with a smattering of interesting items to help you start the day. At least when we uncover a few. Today, though, we are a bit out of order. Nonetheless, we hope you find these helpful...
Novartis To Buy Protez Pharma For Up To $400 Million (Bloomberg News)
AstraZeneca Seeks FDA Approval For Symbicort (Associated Press)
Study Confirms Xolair Is Cost Effective (Yahoo/Reuters)
Glaxo Buys Rights To Two Vertex HIV Drugs (Yahoo/Reuters)